U.K. agency backs expanding indications for rituximab

Submitted by Ross Bonander Thu 12/01/2011

Share on Tumblr

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

Convinced by a steady stream of research, the U.K.'s National Institute for Health and Clinical Excellence (NICE) has chosen to back Rituxan (known in the U.K. as MabThera) as a treatment for people with advanced follicular lymphoma in new draft guidance to be published next month.

NICE, the agency that advises the state-run National Health Service, or NHS, on drugs and therapies that offer a good value for the costs involved, told media outlets in an email that the research behind adding Rituxan to existing chemotherapy regimens leads to longer overall survival rates and a higher quality of life.

This stamp of approval is good news for U.K. patients with indolent non-Hodgkin's lymphomas, particularly those with follicular lymphoma.

Source: Bloomberg

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

Support Groups

SupportGroups.com

For individuals, friends and families who are looking to connect during life's challenging times. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Cancer Support Groups

Find a Treatment Facility Near You

Click on a state below to find Lymphoma treatment options that could be right for you.

Select a State Below

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.